<DOC>
	<DOCNO>NCT00818337</DOCNO>
	<brief_summary>The objective pilot study evaluate prevalence biological aspirin resistance woman risk CHD take low dose ( 81 mg ) aspirin . Aspirin responsiveness measure VerifyNow device ( Accumetrics ; San Diego , CA ) . Those woman identify biologically resistant switch aspirin 325 mg 14 day re-tested aspirin responsiveness .</brief_summary>
	<brief_title>Aspirin Responsiveness Women Risk Cardiac Events</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Women least 19 year old Taking 81 mg aspirin daily , nonenteric coat , least one month primary prevention cardiovascular disease . Able willing provide inform consent Pregnancy breastfeed Known CHD Currently take clopidogrel ticlopidine Use heparin , warfarin , glycoprotein IIb/IIIa inhibitor within previous 96 hour Allergy hypersensitivity salicylate Use OTC prescription analgesic antiinflammatory medication past two week Currently participate another investigational drug device study</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>